[Cost saving program instead of optimizing therapy: disease mismanagement in diabetes mellitus? (interview by Dr. med. Jochen Aumiller)].
Kristian
K
Rett
D000284:Administration, Oral; D017046:Cost Savings; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy* / Q000191:economics; D019468:Disease Management; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005858:Germany; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009313:National Health Programs / Q000191:economics*; D011300:Preoperative Care; D019919:Prosthesis Implantation; D011785:Quality Assurance, Health Care / Q000191:economics*; D012307:Risk Factors
D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin